Envestnet Asset Management Inc Milestone Pharmaceuticals Inc. Transaction History
Envestnet Asset Management Inc
- $302 Billion
- Q3 2024
A detailed history of Envestnet Asset Management Inc transactions in Milestone Pharmaceuticals Inc. stock. As of the latest transaction made, Envestnet Asset Management Inc holds 70,590 shares of MIST stock, worth $146,827. This represents 0.0% of its overall portfolio holdings.
Number of Shares
70,590
Previous 59,523
18.59%
Holding current value
$146,827
Previous $78,000
37.18%
% of portfolio
0.0%
Previous 0.0%
Shares
8 transactions
Others Institutions Holding MIST
# of Institutions
45Shares Held
28.7MCall Options Held
200Put Options Held
0-
Black Rock Inc. New York, NY4.97MShares$10.3 Million0.0% of portfolio
-
Rtw Investments, LP New York, NY3.26MShares$6.77 Million0.08% of portfolio
-
Israel Englander Millennium Management LLC | New York, Ny2.78MShares$5.78 Million0.0% of portfolio
-
Alta Fundamental Advisers LLC New York, NY2.66MShares$5.53 Million1.79% of portfolio
-
Ken Griffin Citadel Advisors LLC | Chicago, Il2.06MShares$4.29 Million0.0% of portfolio
About Milestone Pharmaceuticals Inc.
- Ticker MIST
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 30,010,900
- Market Cap $62.4M
- Description
- Milestone Pharmaceuticals Inc., a biopharmaceutical company, focuses on the development and commercialization of cardiovascular medicines. The company is developing etripamil, a novel channel blocker, which is in Phase III clinical trial for the treatment of paroxysmal supraventricular tachycardia in the United States and Canada; and Phase II cl...